Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis (Q33745961)

29 July 2017

1 reference

title

Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis (English)

1 reference

29 July 2017

0 references

1 reference

Goldenberg MM

1

1 reference

29 July 2017

1 September 1999

1 reference

29 July 2017

Clinical Therapeutics

1 reference

29 July 2017

21

1 reference

29 July 2017

9

1 reference

29 July 2017

1497-513; discussion 1427-8

1 reference

Targets for antiinflammatory drugs

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

NSAID gastropathy. A new understanding

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Prostaglandin endoperoxide synthase: structure and catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Eicosanoids and the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Prostaglandin endoperoxide H synthases-1 and -2.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Structure of the human cyclo-oxygenase-2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Differentiation-associated expression of prostaglandin G/H synthase in monocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Introduction: mechanism of action of NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

1 reference

7 January 2021

Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Nonsteroidal antiinflammatory drugs--differences and similarities

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

Nonsteroidal anti-inflammatory drugs: effects on kidney function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2980005-3

7 January 2021

10.1016/S0149-2918(00)80005-3

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10509845